SuperworthPrecision Biosciences shares outstanding DTIL
Diluted shares outstanding, averaged over each quarter, from 2018.
- Latest quarter, to Jun 30, 2026
- 25.9M
- On a year earlier
- +134.1%
- more shares
Precision Biosciences had 25.9M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 134.1% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 19.1M | +138% |
| FY2024 | 8M | +99% |
| FY2023 | 4M | +8% |
| FY2022 | 3.7M | +83% |
| FY2021 | 2M | +15% |
| FY2020 | 1.8M | +3% |
| FY2019 | 1.7M | +221% |
| FY2018 | 528.3K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 25.9M | +134% | |
| Q1 FY26 | 24.6M | +165% | |
| Q4 FY25 | 19.1M | +138% | |
| Q3 FY25 | 11.8M | +62% | |
| Q2 FY25 | 11M | +58% | |
| Q1 FY25 | 9.3M | +84% | |
| Q4 FY24 | 8M | +99% | |
| Q3 FY24 | 7.3M | +90% | |
| Q2 FY24 | 7M | +84% | |
| Q1 FY24 | 5.1M | +36% | |
| Q4 FY23 | 4M | +8% | |
| Q3 FY23 | 3.8M | +4% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Precision Biosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.